Suppr超能文献

恶性淋巴瘤的免疫诱导:移植物抗宿主模型中供体和宿主肿瘤的鉴定。

Immunologic induction of malignant lymphoma: identification of donor and host tumors in the graft-versus-host model.

作者信息

Gleichmann E, Gleichmann H, Schwartz R S, Weinblatt A, Armstrong Y K

出版信息

J Natl Cancer Inst. 1975 Jan;54(1):107-16. doi: 10.1093/jnci/54.1.107.

Abstract

Primary lymphoid tumors were induced by inoculation of parental line spleen cells into H-2 incompatible F1 hybrid mice. The genotypes of lymphomas arising in 19 different parent yields F1 combinations were determined with cytotoxic antisera against H-2 specificities of donor and host. Additional chromosome marker studies established the reliability of tumor genotyping by the cytotoxicity test. According to H-2 typing, 12 primary lymphomas were of donor type, 66 of host type, and 14 of intermediate type. As a group, those parent yields F1 combinations in which donor-type lymphomas developed (group 1) showed a higher degree of histocompatibility between donor and host than those combinations in which donor-type lymphomas failed to appear (group 2). Allogeneic inhibition may have suppressed the development of donor-type tumors in the combinations of group 2. The development of malignant lymphomas of donor-type in the graft-versus-host reaction (GNHR) supports the concept of lymphomagenesis as a consequence of persistent stimulation by antigen.

摘要

通过将亲代系脾细胞接种到H-2不相容的F1杂种小鼠中诱导原发性淋巴瘤。用针对供体和宿主H-2特异性的细胞毒性抗血清确定了在19种不同亲代产生F1组合中产生的淋巴瘤的基因型。额外的染色体标记研究证实了通过细胞毒性试验进行肿瘤基因分型的可靠性。根据H-2分型,12例原发性淋巴瘤为供体型,66例为主体型,14例为中间型。总体而言,那些产生供体型淋巴瘤的亲代产生F1组合(第1组)中供体和宿主之间的组织相容性程度高于那些未出现供体型淋巴瘤的组合(第2组)。同种异体抑制可能抑制了第2组组合中供体型肿瘤的发展。移植物抗宿主反应(GVHR)中供体型恶性淋巴瘤的发生支持了淋巴瘤发生是抗原持续刺激结果的概念。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验